Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Ultragenyx Pharmaceutical (RARE) Ownership Overview
4.00% Insiders
29.65% Mutual Funds
10.87% Other Institutional Investors
14.67% ETFs
40.81% Public Companies and Individual Investors
The ownership structure of Ultragenyx Pharmaceutical (RARE) stock is a mix of institutional, retail, and individual investors. Approximately 55.19% of the company’s stock is owned by Institutional Investors, 4.00% is owned by Insiders, and 40.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 14, 2025 | xxxxxxxxxxxxx | $250252 | |
Sep 19, 2025 | xxxxxxxxxxxxx | $1867 | |
Jun 23, 2025 | xxxxxxxxxxxxx | $89923 | |
May 05, 2025 | xxxxxxxxxxxxx | $8497 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $384507 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $4002799 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $4476897 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $6754088 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,763,177 | Institution | 8.05% | 255,408,523 | |
| 7,707,498 | Institution | 7.99% | 253,576,684 | |
| 3,769,853 | Institution | 3.91% | 124,028,164 | |
| 2,800,716 | Insider | 2.90% | 92,143,556 | |
| 2,772,692 | Institution | 2.87% | 91,221,567 | |
| 2,482,875 | Institution | 2.57% | 81,686,588 | |
| 2,319,533 | Institution | 2.40% | 76,312,636 | |
| 2,084,411 | Institution | 2.16% | 68,577,122 | |
| 1,656,913 | Institution | 1.72% | 54,512,438 | |
| 1,591,596 | Institution | 1.65% | 52,363,508 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,763,177 | Institution | 8.05% | 255,408,523 | |
| 2,319,533 | Institution | 2.40% | 76,312,636 | |
| 1,656,913 | Institution | 1.72% | 54,512,438 | |
| 1,591,596 | Institution | 1.65% | 52,363,508 | |
| 1,432,289 | Institution | 1.48% | 47,122,308 | |
| 1,054,646 | Institution | 1.09% | 34,697,853 | |
| 998,725 | Institution | 1.04% | 32,858,053 | |
| 744,631 | Institution | 0.77% | 24,498,360 | |
| 703,570 | Institution | 0.73% | 23,147,453 | |
| 626,099 | Institution | 0.65% | 20,598,657 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,824,497 | Institution | 2.93% | 84,960,870 | |
| 2,170,077 | Institution | 2.25% | 65,275,916 | |
| 2,065,794 | Institution | 2.14% | 69,266,073 | |
| 1,210,738 | Institution | 1.25% | 36,418,999 | |
| 1,029,323 | Institution | 1.07% | 30,962,036 | |
| 606,589 | Institution | 0.63% | 19,956,778 | |
| 567,873 | Institution | 0.59% | 18,683,022 | |
| 463,892 | Institution | 0.48% | 15,554,299 | |
| 352,274 | Institution | 0.37% | 11,589,815 | |
| 321,493 | Institution | 0.33% | 10,577,120 |
FAQ
Who Owns Ultragenyx Pharmaceutical (RARE)?
According to the latest TipRanks data, approximately 10.87% of the company's stock is held by institutional investors, 4.00% is held by insiders, and 40.81% is held by retail investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.87% of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors.
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.81% of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors.
Who owns the most shares of Ultragenyx Pharmaceutical (RARE)?
VANGUARD INDEX FUNDS owns the most shares of Ultragenyx Pharmaceutical (RARE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.